{"id":"pemirolast","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PEMIROLAST","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:22:30.453385+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:22:35.743736+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PEMIROLAST","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:22:36.066688+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201198/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:22:36.770333+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:33:28.943Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:22:38.455178+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT03119714","phase":"PHASE2","title":"Pemirolast in Allergen Challenge (PEMAG)","status":"TERMINATED","sponsor":"Karolinska University Hospital","startDate":"2016-11","conditions":"Allergic Asthma","enrollment":1},{"nctId":"NCT02615080","phase":"PHASE2","title":"Safety and Efficacy of CRD007 in Adult Asthma Subjects","status":"COMPLETED","sponsor":"RSPR Pharma AB","startDate":"2015-11-30","conditions":"Asthma","enrollment":168},{"nctId":"NCT02609334","phase":"PHASE2","title":"RSPR-007 Mannitol Challenge Trial","status":"COMPLETED","sponsor":"RSPR Pharma AB","startDate":"2015-03","conditions":"Asthma","enrollment":24},{"nctId":"NCT02517372","phase":"PHASE1","title":"Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast","status":"COMPLETED","sponsor":"RSPR Pharma AB","startDate":"2014-10","conditions":"Healthy Volunteers","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1201198"},"_approvalHistory":[],"publicationCount":55,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"approved","brandName":"PEMIROLAST","genericName":"PEMIROLAST","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1999","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:22:38.455178+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}